Alzheimer's drug aducanumab not approved for use in EU

Alzheimer's drug aducanumab not approved for use in EUAlzheimer's drug aducanumab not approved for use in EU External link

The European Medicines Agency has said no to approving a new drug for Alzheimer's disease in the EU. Aducanumab does not appear to be effective at treating adults with early-stage symptoms, the EMA said.

Tagsalzheimer's
Content typeLINK